Stocks and Investing
Stocks and Investing
Tue, May 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Swayampakula Ramakanth Reiterated (VOR) at Strong Buy and Held Target at $18 on, May 16th, 2023
Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "Vor Biopharma Inc." (VOR) at Strong Buy and Held Target at $18 on, May 16th, 2023.
Swayampakula has made no other calls on VOR in the last 4 months.
There are 5 other peers that have a rating on VOR. Out of the 5 peers that are also analyzing VOR, 0 agree with Swayampakula's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Swayampakula
- Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $18 on, Monday, May 15th, 2023
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $18 on, Friday, May 12th, 2023
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $22 on, Friday, March 24th, 2023
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Friday, March 24th, 2023
- Stephen Willey of "Truist Securities" Maintained at Strong Buy with Decreased Target to $16 on, Friday, March 24th, 2023
Contributing Sources